Mass psychogenic response to human papillomavirus vaccination
- 1 September 2008
- journal article
- review article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 189 (5) , 261-262
- https://doi.org/10.5694/j.1326-5377.2008.tb02018.x
Abstract
Click on the article title to read more.Keywords
This publication has 6 references indexed in Scilit:
- Gardasil™ and mass psychogenic illnessAustralian and New Zealand Journal of Public Health, 2007
- Questions over human papillomavirus vaccine in the US and AustraliaBMJ, 2007
- Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical LesionsNew England Journal of Medicine, 2007
- Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trialsThe Lancet, 2007
- Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trialThe Lancet, 2006
- Mass Psychogenic Illness After VaccinationDrug Safety, 2003